Using the Molecular Classification of Glioblastoma to Inform Personalized Treatment

Ying Mao, Ji Xiong, Zhu-Rong Ye, Rong-Hu Ke, Ying Liu, Yin Wang, Chromosome 1p/19q status combined with expression of p53 protein improves the diagnostic and prognostic evaluation of oligodendrogliomas. Chinese Medical Journal. ,vol. 123, pp. 3566- ,(2010)

Hiroko Ohgaki, Paul Kleihues, Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. Journal of Neuropathology and Experimental Neurology. ,vol. 64, pp. 479- 489 ,(2005) , 10.1093/JNEN/64.6.479

A Tchirkov, C Rolhion, S Bertrand, J-F Doré, J-J Dubost, P Verrelle, IL-6 gene amplification and expression in human glioblastomas. British Journal of Cancer. ,vol. 85, pp. 518- 522 ,(2001) , 10.1054/BJOC.2001.1942

YT Yeung, KL McDonald, T Grewal, L Munoz, Interleukins in glioblastoma pathophysiology: implications for therapy. British Journal of Pharmacology. ,vol. 168, pp. 591- 606 ,(2013) , 10.1111/BPH.12008

Ralf F. Pettersson, A. Jonas Ekstrand, C. David James, V. Peter Collins, V. Peter Collins, Barbara Seliger, Webster K. Cavenee, Genes for Epidermal Growth Factor Receptor, Transforming Growth Factor α, and Epidermal Growth Factor and Their Expression in Human Gliomas in Vivo Cancer Research. ,vol. 51, pp. 2164- 2172 ,(1991)

Rafael Benito, Rosario Gil-Benso, Vicente Quilis, Miguel Perez, Mariela Gregori-Romero, Pedro Roldan, Jose Gonzalez-Darder, Miguel Cerdá-Nicolas, Concha Lopez-Gines, Primary glioblastomas with and without EGFR amplification: Relationship to genetic alterations and clinicopathological features Neuropathology. ,vol. 30, pp. 392- 400 ,(2009) , 10.1111/J.1440-1789.2009.01081.X

Nicola Montano, Tonia Cenci, Maurizio Martini, Quintino Giorgio D’Alessandris, Federica Pelacchi, Lucia Ricci-Vitiani, Giulio Maira, Ruggero De Maria, Luigi Maria Larocca, Roberto Pallini, Expression of EGFRvIII in glioblastoma: prognostic significance revisited. Neoplasia. ,vol. 13, pp. 1113- 1121 ,(2011) , 10.1593/NEO.111338

Christina L. Appin, Jingjing Gao, Candace Chisolm, Mike Torian, Dianne Alexis, Cristina Vincentelli, Matthew J. Schniederjan, Costas Hadjipanayis, Jeffrey J. Olson, Stephen Hunter, Chunhai Hao, Daniel J. Brat, Glioblastoma with oligodendroglioma component (GBM-O): molecular genetic and clinical characteristics. Brain Pathology. ,vol. 23, pp. 454- 461 ,(2013) , 10.1111/BPA.12018

Naoki Shinojima, Kenji Tada, Shoji Shiraishi, Takanori Kamiryo, Masato Kochi, Hideo Nakamura, Keishi Makino, Hideyuki Saya, Hirofumi Hirano, Jun-ichi Kuratsu, Koji Oka, Yasuji Ishimaru, Yukitaka Ushio, None, Prognostic Value of Epidermal Growth Factor Receptor in Patients with Glioblastoma Multiforme Cancer Research. ,vol. 63, pp. 6962- 6970 ,(2003)

Yuchen Jiao, Patrick J. Killela, Zachary J. Reitman, B. Ahmed Rasheed, Christopher M. Heaphy, Roeland F. de Wilde, Fausto J. Rodriguez, Sergio Rosemberg, Sueli Mieko Oba-Shinjo, Suely Kazue Nagahashi Marie, Chetan Bettegowda, Nishant Agrawal, Eric Lipp, Christopher J. Pirozzi, Giselle Y. Lopez, Yiping He, Henry S. Friedman, Allan H. Friedman, Gregory J. Riggins, Matthias Holdhoff, Peter Burger, Roger E. McLendon, Darell D. Bigner, Bert Vogelstein, Alan K. Meeker, Kenneth W. Kinzler, Nickolas Papadopoulos, Luis A. Diaz, Hai Yan, Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas. Oncotarget. ,vol. 3, pp. 709- 722 ,(2012) , 10.18632/ONCOTARGET.588